Rob Bryant

Rob Bryant

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Dr Robert Bryant completed his undergraduate medical degree at the University of Adelaide in 2005 and was awarded Fellowship of the Royal Australasian College of Physicians in 2013, specialising in Gastroenterology. Thereafter, he undertook a Clinical Fellowship in Inflammatory Bowel Diseases under the supervision of Professor Simon Travis at the John Radcliffe Hospital Oxford (2013-2014). He subsequently completed a Master of Science by Research (MScR) at the University of Oxford in the field of genetics and mucosal immunology in inflammatory bowel diseases (2014-2015). Dr Bryant is currently a PhD candidate at the University of Adelaide and works as a Consultant Gastroenterologist within the IBD Service at the Royal Adelaide Hospital.

Dr Bryant is actively involved in research in the field of inflammatory bowel diseases (IBD). He is interested in the influence on diet and the gut microbiome on disease pathogenesis and outcomes in IBD. He is also exploring treatment targets and disease activity assessment in IBD, with an overall goal of improving outcomes for this patient cohort.

    Expand

  • Appointments
    Date Position Institution name
    2018 Clinical Senior Lecturer University of Adelaide
    2017 Staff Specialist Gastroenterologist, Head of Inflammatory Bowel Diseases Queen Elizabeth Hospital
    2016 Basic Physician Training Clinical tutor and examiner Queen Elizabeth Hospital
    2016 Clinical Lecturer, Medical School Lecture Series University of Adelaide
    2016 - 2016 Gastrointestinal Ultrasound Fellowship Sacco University Hospital
    2015 - 2018 Lecturer SAPMEA Postgraduate Medical Education Association lectures
    2015 - 2017 Consultant Gastroenterologist Royal Adelaide Hospital
    2015 Visiting Medical Specialist Alice Springs Hospital
    2014 - 2015 Clinical Research Fellow University of Oxford
    2013 - 2015 Senior Clinical Fellow in Gastroenterology John Radcliffe Hospital
    2011 - 2013 Gastroenterology Advanced Trainee Royal Adelaide Hospital
    2011 - 2012 Academic and clinical tutor, Basic Physician Training Program Royal Adelaide Hospital
    2011 - 2012 Guest lecturer and bedside tutor University of Adelaide
    2008 - 2011 Basic Physician Trainee Royal Adelaide Hospital
    2007 - 2007 Resident Medical Officer Royal Hobart Hospital
    2006 - 2006 Internship Royal Perth Hospital

  • Awards and Achievements
    Date Type Title Institution Name Country Amount
    2016 Scholarship AR Clarkson Scholarship Royal Adelaide Hospital Research Committee Australia —
    2012 Award Mark Jolly Foundation Fellowship Award Royal Adelaide Hospital Australia —
    2012 Award Professor Derek Frewin Clinical Teaching Award School of Medicine, University of Adelaide Australia —
    2010 Award Professor Derek Frewin Clinical Teaching Award School of Medicine, University of Adelaide Australia —
    2004 Award Meritous award for Geriatrics School of Medicine, University of Adelaide Azerbaijan —
    2004 Award Meritous Award for Obstetrics and Gynaecology School of Medicine, University of Adelaide Australia —

  • Education
    Date Institution name Country Title
    2015 University of Adelaide Australia PhD Candidate
    2014 - 2015 University of Oxford United Kingdom Master of Science (by Research) MScR
    2005 University of Adelaide Australia Bachelor of Medicine, Bachelor of Surgery (MBBS)

  • Postgraduate Training
    Date Title Institution Country
    2014 - 2015 Master of Science by Research (MScR) University of Oxford United Kingdom
    2011 - 2013 Fellowship of the Royal Australasian College of Physicians (FRACP) Royal Australasian College of Physicians Australia

  • Research Interests
    Gastroenterology and Hepatology Nutrition and Dietetics
    Expand

  • Journals
    Year Citation
    2021 Goodsall, T. M., Nguyen, T. M., Parker, C. E., Ma, C., Andrews, J. M., Jairath, V., & Bryant, R. V. (2021). Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.. J Crohns Colitis, 15(1), 125-142.
    DOI Scopus7 WoS6 Europe PMC4
    2021 Day, A. S., Wood, J. A., Halmos, E. P., & Bryant, R. V. (2021). Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic. Journal of the Academy of Nutrition and Dietetics, 121(2), 201-209.
    DOI
    2021 Davis, R., Day, A., Barrett, J., Vanlint, A., Andrews, J. M., Costello, S. P., & Bryant, R. V. (2021). Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study. Journal of Human Nutrition and Dietetics, 34(2), 420-428.
    DOI Scopus4 WoS5 Europe PMC3
    2021 Goodsall, T. M., Han, S., & Bryant, R. V. (2021). Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic. Journal of Gastroenterology and Hepatology (Australia), 36(6), 1550-1555.
    DOI Scopus3 WoS3 Europe PMC2
    2021 Day, A. S., Davis, R., Costello, S. P., Yao, C. K., Andrews, J. M., & Bryant, R. V. (2021). The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. Journal of the Academy of Nutrition and Dietetics, 121(4), 688-708.e3.
    DOI
    2021 Ma, C., Sedano, R., Almradi, A., Casteele, N. V., Parker, C. E., Guizzetti, L., . . . Jairath, V. (2021). An International Consensus to Standardize Integration of Histopathology in Ulcerative Colitis Clinical Trials. Gastroenterology, 160(7), 2291-2302.
    DOI Scopus2 Europe PMC1
    2021 Goodsall, T. M., Jairath, V., Feagan, B. G., Parker, C. E., Nguyen, T. M., Guizzetti, L., . . . Ma, C. (2021). Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease. Alimentary Pharmacology and Therapeutics, 53(8), 873-886.
    DOI Scopus7 WoS7 Europe PMC3
    2021 Soo, W. T., Costello, S. P., & Bryant, R. V. (2021). Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 3 pages.
    DOI
    2021 Goodsall, T. M., Jairath, V., Bryant, R. V., & Ma, C. (2021). Editorial: use of intestinal ultrasound in the scoring of Crohn’s disease activity in clinical trials – is it ready for prime time yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 53(8), 948-949.
    DOI
    2021 Goodsall, T. M., Noy, R., Nguyen, T. M., Costello, S. P., Jairath, V., & Bryant, R. V. (2021). Systematic Review: Patient Perceptions of Monitoring Tools in Inflammatory Bowel Disease.. Journal of the Canadian Association of Gastroenterology, 4(2), e31-e41.
    DOI
    2021 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2021). Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study. Journal of Human Nutrition and Dietetics, 11 pages.
    DOI
    2021 Santos-Paulo, S., Costello, S., Forster, S., Travis, S., & Bryant, R. (2021). The gut microbiota as a therapeutic target for obesity: A scoping review. Nutrition Research Reviews, 1-14.
    DOI
    2021 Bryant, R. V., Day, A. S., McGrath, K. C., Telfer, K., Yao, C. K., & Costello, S. P. (2021). Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis. JGH Open.
    DOI
    2021 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2021). Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite, 167, 105650.
    DOI
    2020 Schubert, J. P., Gehlert, J., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., Mangoni, A. A., & Bryant, R. V. (2020). Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis.. Journal of gastroenterology and hepatology, 36(6), 1450-1456.
    DOI Scopus1 WoS1
    2020 Meyer, E. J., Mignone, E., Hade, A., Thiruvenkatarajan, V., Bryant, R. V., & Jesudason, D. (2020). Periprocedural euglycemic diabetic ketoacidosis associated with sodium– glucose cotransporter 2 inhibitor therapy during colonoscopy. Diabetes Care, 43(11), e181-e184.
    DOI Scopus3 WoS5 Europe PMC2
    2020 Aysha, A. A., Rentsch, C., Prentice, R., Johnson, D., Bryant, R. V., Ward, M. G., . . . Christensen, B. (2020). Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty. Internal Medicine Journal, 50(7), 798-804.
    DOI Scopus4 WoS4 Europe PMC2
    2020 Vanlint, A. S., Kaazan, P., Kwok, M., Bryant, R. V., Ooi, M., Bak, N., & Costello, S. (2020). Lessons from practice Low attenuation lymphadenopathy on computed tomography leading to diagnosis of Whipple disease. Medical Journal of Australia, 213(4), 161-162.e1.
    DOI
    2020 Gill, M., Blacketer, C., Chitti, F., Telfer, K., Papanicolas, L., Dann, L. M., . . . Costello, S. P. (2020). Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank. JGH Open, 4(5), 950-957.
    DOI
    2020 Costello, S. P., Day, A., Yao, C. K., & Bryant, R. V. (2020). Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis. BMJ Case Reports, 13(8), e233135.
    DOI Scopus5 Europe PMC3
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough. Journal of Crohn's and Colitis, 14(10), 1341-1342.
    DOI Europe PMC1
    2020 Day, A., Wood, J., Melton, S., & Bryant, R. V. (2020). Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease. JGH Open, 4(2), 260-266.
    DOI Scopus4 Europe PMC3
    2020 Rajagopalan, A., Sathananthan, D., An, Y. K., Van De Ven, L., Martin, S., Fon, J., . . . Bryant, R. V. (2020). Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. JGH Open, 4(2), 267-272.
    DOI Scopus8 Europe PMC4
    2020 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Martin, S., Fon, J., Costello, S., & Bryant, R. V. (2020). Point-of-care gastrointestinal ultrasound in inflammatory bowel disease: An accurate alternative for disease monitoring. JGH Open, 4(2), 273-279.
    DOI Scopus5 Europe PMC1
    2020 Costello, S. P., & Bryant, R. V. (2020). Editorial: faecal microbiota transplantation—the silver bullet for severe and fulminant Clostridioides difficile infection?. Alimentary Pharmacology and Therapeutics, 51(1), 180-181.
    DOI
    2020 Soo, W. T., Bryant, R. V., & Costello, S. P. (2020). Faecal microbiota transplantation: Indications, evidence and safety. Australian Prescriber, 43(2), 36-38.
    DOI
    2020 Flanagan, E., Wright, E. K., Begun, J., Bryant, R. V., An, Y. K., Ross, A. L., . . . Bell, S. J. (2020). Monitoring Inflammatory Bowel Disease in Pregnancy Using Gastrointestinal Ultrasonography. Journal of Crohn's and Colitis, 14(10), 1405-1412.
    DOI Scopus5 WoS4 Europe PMC1
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). COVID-19 and implications for thiopurine use. Medical Journal of Australia, 212(10), 490-490.e1.
    DOI Scopus3 WoS3 Europe PMC1
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). ABC of topical therapy in inflammatory bowel disease. JGH Open, 4(4), 556-557.
    DOI
    2019 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2019). Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflammatory bowel diseases, 25(3), 592-600.
    DOI Scopus14 WoS11 Europe PMC8
    2019 Oakland, K., Kahan, B., Guizzetti, L., Martel, M., Bryant, R., Brahmania, M., . . . Jairath, V. (2019). Development, Validation, and Comparative Assessment of an International Scoring System to Determine Risk of Upper Gastrointestinal Bleeding. Clinical Gastroenterology and Hepatology, 17(6), 1121.
    DOI Scopus11 WoS12 Europe PMC7
    2019 Bryant, R. V., Schultz, C. G., Ooi, S., Goess, C., Costello, S. P., Vincent, A. D., . . . Andrews, J. M. (2019). Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Inflammatory bowel diseases, 25(6), e62-e63.
    DOI
    2019 Costello, S., Hughes, P., Waters, O., Bryant, R., Vincent, A., Blatchford, P., . . . Andrews, J. (2019). Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA - Journal of the American Medical Association, 321(2), 156-164.
    DOI Scopus208 WoS204 Europe PMC22
    2019 Costello, S. P., & Bryant, R. V. (2019). Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Internal Medicine Journal, 49(2), 148-151.
    DOI Scopus6 WoS6 Europe PMC5
    2019 Wardill, H., Secombe, K., Bryant, R., Hazenberg, M., & Costello, S. (2019). Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine, 44, 730-740.
    DOI Scopus22 WoS21 Europe PMC13
    2019 Bryant, R. V., & Costello, S. P. (2019). Editorial: assessing histological disease activity in Crohn’s disease—a call for standardisation of mucosal biopsy location. Alimentary Pharmacology and Therapeutics, 50(1), 103-104.
    DOI Scopus2 WoS2 Europe PMC1
    2019 Biswas, S., Bryant, R. V., & Travis, S. (2019). Interfering with leukocyte trafficking in Crohn's disease. Best Practice and Research: Clinical Gastroenterology, 38-39, 8 pages.
    DOI Scopus13 WoS13 Europe PMC5
    2019 Roberts-Thomson, I. C., Bryant, R. V., & Costello, S. P. (2019). Uncovering the cause of ulcerative colitis. JGH Open, 3(4), 274-276.
    DOI Scopus4 Europe PMC2
    2019 Liu, J., Andrews, J. M., Sammour, T., Bryant, R. V., Grafton, R., Simpson, E., . . . Nixon, C. (2019). Benefits of exclusive enteral nutrition in adults with complex active Crohn's disease: A case series of 13 consecutive patients. Crohn's and Colitis 360, 1(3).
    DOI Scopus1
    2018 Schwerd, T., Bryant, R., Pandey, S., Capitani, M., Meran, L., Cazier, J. -B., . . . Uhlig, H. (2018). NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease.. Mucosal immunology, 11(2), 562-574.
    DOI Scopus42 WoS37 Europe PMC24
    2018 Bryant, R. V., Friedman, A. B., Wright, E. K., Taylor, K. M., Begun, J., Maconi, G., . . . Gibson, P. R. (2018). Gastrointestinal ultrasound in inflammatory bowel disease: An underused resource with potential paradigm-changing application. Gut, 67(5), 973-985.
    DOI Scopus51 WoS50 Europe PMC16
    2018 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Knight, E., Lau, S. -Y., . . . Andrews, J. (2018). Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice. Journal of gastroenterology and hepatology, 33(3), 599-607.
    DOI Scopus18 WoS16 Europe PMC9
    2018 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2018). Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of Myopenia and Osteopenia. Nutrients, 10(9), 1192-1-1192-17.
    DOI Scopus24 WoS24 Europe PMC11
    2017 Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 46(6), 631-632.
    DOI
    2017 Bryant, R., Prowse, S., Nguyen-Hoang, A., & Lewis, M. (2017). Gastrointestinal: Adenocarcinoma in ileal Crohn's disease: A devil in disguise. Journal of Gastroenterology and Hepatology (Australia), 32(9), 1535.
    DOI Scopus1 WoS1 Europe PMC1
    2017 Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., . . . Leong, R. W. (2017). Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 46(11-12), 1037-1053.
    DOI Scopus141 WoS134 Europe PMC70
    2017 Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., MacOni, G., . . . Dietrich, C. (2017). How to perform gastrointestinal ultrasound: Anatomy and normal findings. World Journal of Gastroenterology, 23(38), 6931-6941.
    DOI Scopus27 WoS28 Europe PMC17
    2017 Bezzio, C., Bryant, R. V., Manes, G., Maconi, G., & Saibeni, S. (2017). New horizons in the imaging of perianal Crohn’s disease: transperineal ultrasonography. Expert Review of Gastroenterology and Hepatology, 11(6), 523-530.
    DOI Scopus4 WoS2 Europe PMC3
    2017 Costello, S., Soo, W., Bryant, R., Jairath, V., Hart, A., & Andrews, J. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology and Therapeutics, 46(3), 213-224.
    DOI Scopus114 WoS115 Europe PMC76
    2017 Guirgis, M., Wendt, E., Wang, L. M., Walsh, A., Burger, D., Bryant, R. V., . . . Keshav, S. (2017). Beyond Histological Remission: Intramucosal Calprotectin as a Potential Predictor of Outcomes in Ulcerative Colitis. Journal of Crohn's and Colitis, 11(4), jjw174.
    DOI Scopus8 WoS7 Europe PMC3
    2016 Atkinson, N., Bryant, R., Dong, Y., Maaser, C., Kucharzik, T., Maconi, G., . . . Dietrich, C. (2016). WFUMB Position Paper. Learning Gastrointestinal Ultrasound: Theory and Practice. Ultrasound in Medicine and Biology, 42(12), 2732-2742.
    DOI Scopus28 WoS27 Europe PMC13
    2016 Bryant, R. V., Burger, D. C., Delo, J., Walsh, A. J., Thomas, S., Von Herbay, A., . . . Travis, S. P. L. (2016). Beyond endoscopic mucosal healing in UC: Histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut, 65(3), 408-414.
    DOI Scopus174 WoS175 Europe PMC101
    2016 Bennett, A., Moore, D., Bampton, P., Bryant, R., & Andrews, J. (2016). Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World Journal of Gastroenterology, 22(8), 2611-2620.
    DOI Scopus22 WoS24 Europe PMC13
    2016 Hughes, P., Costello, S., Bryant, R., & Andrews, J. (2016). Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications. American Journal of Physiology, 311(3), G501-G513.
    DOI Scopus13 WoS12 Europe PMC9
    2016 Walsh, A., Bryant, R., & Travis, S. (2016). Current best practice for disease activity assessment in IBD. Nature Reviews Gastroenterology and Hepatology, 13(10), 567-579.
    DOI Scopus86 WoS87 Europe PMC52
    2016 Griffiths, E., McDonald, C., Bryant, R., Devitt, P., Bright, T., Holloway, R., & Thompson, S. (2016). Retrospective analysis of surgery and trans-arterial embolization for major non-variceal upper gastrointestinal bleeding. ANZ Journal of Surgery, 86(5), 381-385.
    DOI Scopus8 WoS7 Europe PMC5
    2015 Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2015). Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 41(9), 895-906.
    DOI Scopus69 WoS69 Europe PMC38
    2015 Bryant, R. V., & Andrews, J. M. (2015). Letter: low muscle mass and disordered eating as causes of osteopenia in inflammatory bowel disease - authors' reply. Alimentary Pharmacology and Therapeutics, 41(12), 1304-1305.
    DOI Scopus1 WoS1 Europe PMC1
    2015 Bryant, R. V., Costello, S. P., & Andrews, J. M. (2015). Editorial: Untangling symptoms from mucosal healing in UC - A note of caution for patient-reported outcomes. Alimentary Pharmacology and Therapeutics, 42(11-12), 1327-1328.
    DOI Scopus1 WoS1 Europe PMC1
    2015 Peyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., . . . Colombel, J. F. (2015). Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target. American Journal of Gastroenterology, 110(9), 1324-1338.
    DOI Scopus881 WoS844 Europe PMC492
    2015 Bryant, R. V., Brain, O., & Travis, S. P. L. (2015). Conventional drug therapy for inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 50(1), 90-112.
    DOI Scopus42 WoS38 Europe PMC26
    2015 Bryant, R. V., Sandborn, W. J., & Travis, S. P. L. (2015). Introducing vedolizumab to clinical practice: Who, when, and how?. Journal of Crohn's and Colitis, 9(4), 356-366.
    DOI Scopus39 WoS36 Europe PMC31
    2015 Bryant, R. V., Winer, S., Travis, S. P. L., & Riddell, R. H. (2015). Response to Villanacci et. al. Journal of Crohn's & colitis, 9(5), 429.
    DOI
    2014 Bryant, R. V., Winer, S., SPL, T., & Riddell, R. H. (2014). Systematic review: Histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative. Journal of Crohn's and Colitis, 8(12), 1582-1597.
    DOI Scopus155 WoS148 Europe PMC102
    2014 Bryant, R., Jairath, V., Curry, N., & Travis, S. (2014). Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?. Journal of Crohn's and Colitis, 8(2), 166-171.
    DOI Scopus18 WoS18 Europe PMC11
    2013 Bryant, R., Trott, M., Bartholomeusz, F., & Andrews, J. (2013). Systematic review: Body composition in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 38(3), 213-225.
    DOI Scopus88 WoS84 Europe PMC57
    2013 Bryant, R., Trott, M., Bennett, A., Bampton, P., Moore, D., & Andrews, J. (2013). Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. Internal Medicine Journal, 43(11), 1171-1176.
    DOI Scopus4 WoS3 Europe PMC3
    2013 Bryant, R., Kuo, P., Williamson, K., Yam, C., Schoeman, M., Holloway, R., & Nguyen, Q. (2013). Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding. Gastrointestinal Endoscopy, 78(4), 576-583.
    DOI Scopus72 WoS64 Europe PMC43
    2013 Bryant, R., Schoeman, S., & Schoeman, M. (2013). Shorter preparation to procedure interval for colonoscopy improves quality of bowel cleansing. Internal Medicine Journal, 43(2), 162-168.
    DOI Scopus16 WoS15 Europe PMC12
    2012 Bryant, R., Holloway, R., & Nguyen, N. (2012). Gastrointestinal: role of endoscopic ultrasound in the evaluation of pseudoachalasia. Journal of Gastroenterology and Hepatology, 27(6), 1128.
    DOI Scopus8 WoS6 Europe PMC1
    2011 Bryant, R., Schoeman, S., & Schoeman, M. (2011). Split vs single day preparation and colonoscopy outcomes in a large single Australian centre. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 26, 75.
    2011 Bryant, R., Van Langenberg, D., Holtmann, G., & Andrews, J. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology, 26(5), 916-923.
    DOI Scopus57 WoS53 Europe PMC43
    2010 Andrews, J., Bryant, R., Van Langenberg, D., & Holtmann, G. (2010). Are all symptoms in patients in IBD due to occult inflammation. American Journal of Gastroenterology, 105(12), 2703.
    DOI Scopus3 WoS2

  • Conference Items
    Year Citation
    2018 Rajagopalan, A., Sathananthan, D., Van De Ven, L., Martin, S., Fon, J., Costello, S., & Bryant, R. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Acceptability, tolerability, and impact on illness-related knowledge. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2018 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Fon, J., Costello, S., & Bryant, R. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Accuracy compared with colonoscopy and fecal calprotectin. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2016 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Lau, S., Schoeman, M., . . . Andrews, J. (2016). Treat to target' in ulcerative colitis (UC) in the Australian setting: current practice and potential barriers? A multi-site cross-sectional evaluation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.
    2016 Bryant, R., Costello, S., Tee, D., Schoeman, S., Mountifield, R., & Andrews, J. (2016). Australian gastroenterologists' perceptions of 'treat to target' recommendations for ulcerative colitis: a survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.
    2015 Pilichiewicz, A., Goess, C., Linedale, E., Ooi, S., Bryant, R., Grafton, R., . . . Andrews, J. (2015). Nutrient intake in patients with inflammatory bowel disease: Are they meeting their dietary requirements?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.
    2014 Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2014). SARCOPAENIA MEASURED BY DXA IS COMMON IN IBD PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
    2014 Lim, A., Ooi, S., Bryant, R., Schultz, C., Goess, C., Grafton, R., . . . Andrews, J. (2014). The effects of vitamin D deficiency in patients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Broadbeach, Qld.: Wiley.
    DOI
    2012 Nguyen, N. Q., Bryant, R. V., Kuo, P., Williamson, K. D., Schoeman, M., & Holloway, R. H. (2012). Risk Stratification With Glasgow-Blatchford Bleeding Score for Hospitalized Patients With Upper Gastrointestinal Bleeding Can Avoid the Needs for Urgent Endo-Therapy. Poster session presented at the meeting of GASTROINTESTINAL ENDOSCOPY. San Diego, CA: MOSBY-ELSEVIER.
    WoS2
    2012 Rahman, A. H. A., Hrycek, C., Bryant, R. V., Andrews, J., Nguyen, N., Schoeman, M., & Holloway, R. (2012). Is there a 'weekend effect' among patients referred to a dedicated 'haematemesis and melaena' service?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Adelaide, SA: Wiley.
    DOI
    Expand

  • Current Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2021 Co-Supervisor Faecal Microbiota Transplant (FMT) as a safe and efficacious therapeutic alternative for refractory proctitis Master of Philosophy (Medical Science) Master Full Time Dr Sreecanth Raja
    2021 Co-Supervisor Improving treatment outcome of Helicobacter pylori infection Doctor of Philosophy Doctorate Full Time Mr Jonathon Paul Schubert
    2020 Co-Supervisor Development of a gastrointestinal ultrasound idex for inflammatory bowel disease activity Master of Philosophy (Medical Science) Master Full Time Dr Tom Goodsall
    2018 Co-Supervisor Diet in Inflammatory Bowel Disease - What's Being Eaten and Can a Defined Strategy Help? Doctor of Philosophy Doctorate Full Time Mrs Alice Sarah Day

  • Other Supervision Activities
    Date Role Research Topic Location Program Supervision Type Student Load Student Name
    2018 - ongoing Principal Supervisor Dietetic Flinders University — Honours — Rachel Davis
    2018 - ongoing Principal Supervisor Gastroenterology Advanced Training Research Project University of Adelaide — Other — Dr Arvind Rajagopalan
    Expand

  • Committee Memberships
    Date Role Committee Institution Country
    2017 - ongoing Member Australiasian Society for Parenteral and Enteral Nutrition (AUSPEN) Australiasian Society for Parenteral and Enteral Nutrition (AUSPEN) Australia
    2016 - ongoing Member GENIUS Gastrointestinal Ultrasound Inaugural GENIUS Gastrointestinal Ultrasound Inaugural Australia
    2014 - ongoing Member Conjoint Committee Recognition of Training Gastrointestinal Endoscopy, Upper Endoscopy and Colonoscopy, Gastroenterological Society of Australia (GESA) Gastroenterological Society of Australia (GESA) Australia

  • Memberships
    Date Role Membership Country
    2015 - ongoing Member Crohn’s Colitis Foundation Australia
    2014 - ongoing Member British Society of Immunology United Kingdom
    2013 - ongoing Member European Crohn’s and Colitis Organisation Denmark
    2013 - ongoing Member British Society of Gastroenterology Ukraine
    2012 - ongoing Member American Gastroenterology Association United States
    2011 - ongoing Member Gastroenterological Society of Australia Australia
    2010 - ongoing Member Royal Australasian College of Physicians Australia
    2008 - 2012 Member Royal Adelaide Hospital Resident Medical Officers Association Australia
Connect With Me
External Profiles